American Century Companies’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Buy |
1,724,307
+71,815
| +4% | +$1.01M | 0.01% | 1000 |
|
|
2025
Q1 | $25.8M | Buy |
1,652,492
+21,266
| +1% | +$333K | 0.02% | 917 |
|
|
2024
Q4 | $22.7M | Buy |
1,631,226
+166,915
| +11% | +$2.33M | 0.01% | 981 |
|
|
2024
Q3 | $13.6M | Buy |
1,464,311
+232,611
| +19% | +$2.16M | 0.01% | 1183 |
|
|
2024
Q2 | $11.5M | Buy |
1,231,700
+190,754
| +18% | +$1.77M | 0.01% | 1190 |
|
|
2024
Q1 | $10.3M | Buy |
1,040,946
+129,143
| +14% | +$1.28M | 0.01% | 1193 |
|
|
2023
Q4 | $2.95M | Buy |
911,803
+401,709
| +79% | +$1.3M | ﹤0.01% | 1598 |
|
|
2023
Q3 | $2.71M | Buy |
510,094
+215
| +0% | +$1.14K | ﹤0.01% | 1574 |
|
|
2023
Q2 | $4.86M | Buy |
509,879
+1,860
| +0.4% | +$17.7K | ﹤0.01% | 1323 |
|
|
2023
Q1 | $5.58M | Sell |
508,019
-72,870
| -13% | -$800K | ﹤0.01% | 1227 |
|
|
2022
Q4 | $8.6M | Sell |
580,889
-2,047
| -0.4% | -$30.3K | 0.01% | 1024 |
|
|
2022
Q3 | $11.1M | Buy |
582,936
+18,292
| +3% | +$350K | 0.01% | 851 |
|
|
2022
Q2 | $12M | Buy |
564,644
+40,085
| +8% | +$854K | 0.01% | 846 |
|
|
2022
Q1 | $10.1M | Buy |
524,559
+37,488
| +8% | +$722K | 0.01% | 914 |
|
|
2021
Q4 | $10.1M | Buy |
487,071
+110,997
| +30% | +$2.3M | 0.01% | 881 |
|
|
2021
Q3 | $8.99M | Sell |
376,074
-546
| -0.1% | -$13K | 0.01% | 874 |
|
|
2021
Q2 | $10.3M | Buy |
376,620
+824
| +0.2% | +$22.5K | 0.01% | 805 |
|
|
2021
Q1 | $10.9M | Buy |
375,796
+87,496
| +30% | +$2.53M | 0.01% | 761 |
|
|
2020
Q4 | $8.11M | Buy |
+288,300
| New | +$8.11M | 0.01% | 799 |
|